Non-Recommended Cervical Cancer Screening in Adolescent Females (NCS)

Assesses adolescent females 16–20 years of age who were screened unnecessarily for cervical cancer.

Note: A lower rate indicates better performance.

Why It Matters

Cervical cancer screening can result in more harm than benefits for adolescent females. Adolescent females tend to have high rates of transient HPV infection and regressive cervical abnormalities. This may produce false-positive results and lead to unnecessary and potentially detrimental follow-up tests and treatment.¹

Results

Non-Recommended Cervical Cancer Screening in Adolescent Females*

Measure YearCommercial HMOCommercial PPOMedicaid HMO
20190.90.90.8
20181.11.11
20171.51.51.5
20161.81.92
20152.32.42.7
20143.43.83.8

This State of Healthcare Quality Report classifies health plans differently than NCQA’s Quality Compass. HMO corresponds to All LOBs (excluding PPO and EPO) within Quality Compass. PPO corresponds to PPO and EPO within Quality Compass.

Figures do not account for changes in the underlying measure that could break trending. Contact Information Products via my.ncqa.org for analysis that accounts for trend breaks.

References

  1. Kulasingam, S.L, L. Havrilesky, R. Ghebre, E.R Myers. 2011. “Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.” Agency for Healthcare Research and Quality. Report No.: 11-05157-EF-1. Rockville, MD

  • Save

    Save your favorite pages and receive notifications whenever they’re updated.

    You will be prompted to log in to your NCQA account.

  • Email

    Share this page with a friend or colleague by Email.

    We do not share your information with third parties.

  • Print

    Print this page.